Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 215

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 8
Chunk 215
---
.05 of Form 8-K regarding amendment to, or waiver from, a provision of our Code of Business Conduct and Ethics, as well as
Nasdaq’s requirement to disclose waivers with respect to directors and executive officers, by posting such information on our website
at texhe address and location specified above. The information contained on our website is not incorporated by reference into this Annual
Report.

Insider
Trading Policy

We
have adopted an insider trading policy that governs the purchase, sale, and/or other transactions of our securities by our directors,
officers and certain other covered persons, and which is reasonably designed to promote compliance with applicable insider trading laws,
rules and regulations, and any listing standards applicable to us. A copy of our insider trading policy is filed as Exhibit 19.1 to this
Annual Report on Form 10-K. In addition, with regard to any trading in our own securities, it is our policy to comply with the federal
securities laws and the applicable exchange listing requirements.

Committees
of the Board

Our
Board has established four standing committees—Audit, Compensation, Nominating, and Science and Technology. Each of Audit, Compensation
and Nominating Committee operates under a written charter that has been approved by our Board.

The
members of each of the Board committees and committee Chairpersons are set forth in the following chart.

    Name
     
    Audit
     
    Compensation
     
    Nominating
     
    Science and
    Technology

    Mark J. Gilbert, M.D.

    X

    William B. Hayes
     
    Chairperson
     
    X

    Hila Karah
     
    X

    Chairperson

    Anthony J. Maddaluna

    Chairperson
     
    X
     
    X

    Robert E. Martell, M.D., Ph.D.
     
    X

    X

    Michael J. Newman, Ph.D.

    Chairperson

77

Audit
Committee

Our
Audit Committee’s responsibilities include:

    ●
    appointing,
    approving the compensation of, and assessing the independence of our independent registered public accounting firm;

    ●
    monitoring the rotation
    of the partners of our independent registered public accounting firm on our audit engagement team and considering periodically the
    rotation of auditing firms;

    ●
    overseeing the work of
    our independent registered public accounting firm;

    ●
    reviewing and discussing